Cite
Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
MLA
Juan Du, et al. “Inhibition of the IGF Signaling Pathway Reverses Cisplatin Resistance in Ovarian Cancer Cells.” BMC Cancer, vol. 17, Dec. 2017, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12885-017-3840-1.
APA
Juan Du, Hui-rong Shi, Fang Ren, Jing-lu Wang, Qing-hua Wu, Xia Li, Rui-tao Zhang, Du, J., Shi, H.-R., Ren, F., Wang, J.-L., Wu, Q.-H., Li, X., & Zhang, R.-T. (2017). Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells. BMC Cancer, 17, 1–11. https://doi.org/10.1186/s12885-017-3840-1
Chicago
Juan Du, Hui-rong Shi, Fang Ren, Jing-lu Wang, Qing-hua Wu, Xia Li, Rui-tao Zhang, et al. 2017. “Inhibition of the IGF Signaling Pathway Reverses Cisplatin Resistance in Ovarian Cancer Cells.” BMC Cancer 17 (December): 1–11. doi:10.1186/s12885-017-3840-1.